320 related articles for article (PubMed ID: 25868284)
1. [Research progress in the structure and function of dengue virus non-structural 1 protein].
Chen Y; Ren RW; Liu JW
Bing Du Xue Bao; 2014 Nov; 30(6):683-8. PubMed ID: 25868284
[TBL] [Abstract][Full Text] [Related]
2. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
3. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
6. The dengue virus non-structural 1 protein: risks and benefits.
Amorim JH; Alves RP; Boscardin SB; Ferreira LC
Virus Res; 2014 Mar; 181():53-60. PubMed ID: 24434336
[TBL] [Abstract][Full Text] [Related]
7. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
[TBL] [Abstract][Full Text] [Related]
8. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
Liang H; Lee M; Jin X
Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
[TBL] [Abstract][Full Text] [Related]
9. Vaccines and immunization strategies for dengue prevention.
Liu Y; Liu J; Cheng G
Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus.
Xie X; Zou J; Wang QY; Noble CG; Lescar J; Shi PY
Virology; 2014 Feb; 450-451():250-7. PubMed ID: 24503088
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
Gelanew T; Poole-Smith BK; Hunsperger E
J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
[TBL] [Abstract][Full Text] [Related]
12. The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.
Glasner DR; Puerta-Guardo H; Beatty PR; Harris E
Annu Rev Virol; 2018 Sep; 5(1):227-253. PubMed ID: 30044715
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
[TBL] [Abstract][Full Text] [Related]
14. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
[TBL] [Abstract][Full Text] [Related]
15. Targets and strategies for vaccine development against dengue viruses.
Wang WH; Urbina AN; Lin CY; Yang ZS; Assavalapsakul W; Thitithanyanont A; Lu PL; Chen YH; Wang SF
Biomed Pharmacother; 2021 Dec; 144():112304. PubMed ID: 34634560
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
Chen HR; Lai YC; Yeh TM
J Biomed Sci; 2018 Jul; 25(1):58. PubMed ID: 30037331
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in dengue vaccine development.
Wei J; Chen H; An J
Virol Sin; 2014 Dec; 29(6):353-63. PubMed ID: 25547681
[TBL] [Abstract][Full Text] [Related]
18. Salivary Detection of Dengue Virus NS1 Protein with a Label-Free Immunosensor for Early Dengue Diagnosis.
Wasik D; Mulchandani A; Yates MV
Sensors (Basel); 2018 Aug; 18(8):. PubMed ID: 30103543
[TBL] [Abstract][Full Text] [Related]
19. A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine.
Choy MM; Ng DHL; Siriphanitchakorn T; Ng WC; Sundstrom KB; Tan HC; Zhang SL; Chan KWK; Manuel M; Kini RM; Chan KR; Vasudevan SG; Ooi EE
Cell Rep; 2020 May; 31(6):107617. PubMed ID: 32402284
[TBL] [Abstract][Full Text] [Related]
20. Dengue vaccine candidates in development.
Durbin AP; Whitehead SS
Curr Top Microbiol Immunol; 2010; 338():129-43. PubMed ID: 19802583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
